This is a routine proxy notice with no material trading implications. Monitor the definitive proxy statement (DEF 14A) when filed for any dissident shareholder activity or material compensation changes. The annual meeting date is set — no immediate catalyst.
Price Chart
Executive Summary
LeonaBio, Inc. filed a DEFA14A (additional definitive proxy soliciting materials) providing notice of its 2026 Annual Meeting to be held on June 22, 2026. The filing outlines four standard proposals: election of three Class III directors, ratification of Ernst & Young as auditor, advisory vote on executive compensation, and advisory vote on the frequency of future say-on-pay votes. The board recommends 'For' votes on all proposals. This is a routine administrative filing with no material financial or strategic content.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for June 22, 2026, to be held virtually
- Proposal 1: Election of Class III directors — nominees Kelly A. Romano, James A. Johnson, Natalie Holles
- Proposal 2: Ratification of Ernst & Young LLP as independent auditor for FY ending December 31, 2026
- Proposal 3: Advisory vote on named executive officer compensation
- Proposal 4: Advisory vote on frequency of future say-on-pay votes (board recommends 3 years)
- Record date and detailed proxy statement not included in this filing
- Company was formerly known as Athira Pharma, Inc. and M3 Biotechnology, Inc.
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No material risks identified from this routine filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-217016 |
| Document: 0001193125-26-217016-index-headers.html | 0001193125-26-217016 |
| Document: 0001193125-26-217016-index.html | 0001193125-26-217016 |
| Document: 0001193125-26-217016.txt | 0001193125-26-217016 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13D/A | $4.79 | awaiting T+60 | — | $4.77 (−0.42%) |
May 11, 2026 24w ago | DEFA14A | $10.17 $7.81 | ▼ −23.21% | ▼ −27.59% | $4.77 (−53.10%) |
May 7, 2026 24w ago | 3 | $10.04 $7.66 | ▼ −23.71% | ▼ −28.54% | $4.77 (−52.49%) |
Apr 23, 2026 26w ago | Press Release | $8.33 $7.98 | ▼ −4.20% | ▼ −9.28% | $4.77 (−42.74%) |
Mar 26, 2026 30w ago | Press Release | $8.97 $8.41 | ▼ −6.24% | ▼ −22.31% | $4.77 (−46.82%) |
Mar 4, 2026 33w ago | Insider Cluster | $5.98 $9.64 | ▲ +61.20% | ▲ +51.12% | $4.77 (−20.23%) |
Mar 4, 2026 33w ago | Insider Cluster | $5.98 $9.64 | ▲ +61.20% | ▲ +51.12% | $4.77 (−20.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers